17-58206081-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PM4
The NM_017777.4(MKS1):c.1678T>C(p.Ter560Glnext*?) variant causes a stop lost change. The variant allele was found at a frequency of 0.00000559 in 1,610,218 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_017777.4 stop_lost
Scores
Clinical Significance
Conservation
Publications
- Meckel syndrome, type 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae)
- Bardet-Biedl syndrome 13Inheritance: Unknown, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- Joubert syndrome 28Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Bardet-Biedl syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Joubert syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Joubert syndrome with ocular defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Meckel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152140Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000412 AC: 6AN: 1458078Hom.: 0 Cov.: 32 AF XY: 0.00000414 AC XY: 3AN XY: 725170 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74336 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: MKS1 c.1678T>C (p.X560GlnextX51) changes the termination codon and is predicted to lead to an extended protein with additional amino acids added to the normal C-terminus. MKS1 c.1678T>C (p.X560GlnextX51) causes a frameshift which results in an extension of the protein. The variant was absent in 239006 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.1678T>C in individuals affected with Meckel Syndrome Type 1 and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
MKS1-related disorder Uncertain:1
The MKS1 c.1678T>C variant is predicted to result in extension of the open reading frame (p.*560Glnext*51). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.013% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Meckel-Gruber syndrome;C0431399:Joubert syndrome Uncertain:1
This sequence change disrupts the translational stop signal of the MKS1 mRNA. It is expected to extend the length of the MKS1 protein by 51 additional amino acid residues. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with MKS1-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at